Importantly, the enhanced circulating levels of AGEs reported in both COPD and CVD likely exacerbate the negative effects of AGE-RAGE through endothelial cells and cells in the circulation, especially in the context of attenuated circulating sRAGE levels (Figure 7). Here, AGER is linked to chronic obstructive pulmonary disease.